Market closedADR
Fresenius Medical Care/$FMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Ticker
$FMS
Sector
NON_CLASSIFIED
Trading on
NYSE
Industry
Healthcare Facilities
Headquarters
Bad homburg vor der hohe, Germany
Employees
124,295
Website
FMS Metrics
BasicAdvanced
$13B
21.95
$2.03
0.92
$1.12
2.51%
Price and volume
Market cap
$13B
Beta
0.92
52-week high
$49.62
52-week low
$25.95
Average daily volume
9.3M
Dividend rate
$1.12
Financial strength
Current ratio
1.26
Quick ratio
0.908
Long term debt to equity
79.894
Total debt to equity
96.582
Dividend payout ratio (TTM)
55.24%
Enterprise value to free cash flow
14.292
Interest coverage (TTM)
7.54%
Management effectiveness
Return on assets (TTM)
2.27%
Return on equity (TTM)
4.32%
Return on investment (TTM)
2.94%
Valuation
Price to earnings (TTM)
21.946
Price to revenue (TTM)
0.666
Price to book
0.966
Price to free cash flow (TTM)
7.399
Five year average dividend yield
2.22%
Dividend yield (TTM)
2.51%
Forward dividend yield
2.51%
Growth
Revenue change (TTM)
6.68%
Earnings per share change (TTM)
-26.23%
3-year revenue growth (CAGR)
3.54%
3-year earnings per share growth (CAGR)
-16.63%
3-year dividend per share growth (CAGR)
-2.27%
What the Analysts think about FMS
Analyst Ratings
Majority rating from 5 analysts.
FMS Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 23
QoQ growth
Revenue
€4.8B
2.57%
Net income
€140M
62.57%
Profit margin
2.90%
58.47%
FMS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
€0.30
€0.29
€0.44
€0.41
-
Expected
€0.28
€0.31
€0.30
€0.25
€0.32
Surprise
5.36%
8.06%
47.24%
67.34%
-
FMS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Fresenius Medical Care stock?
Fresenius Medical Care (FMS) has a market cap of $13B as of April 24, 2025.
What is the P/E ratio for Fresenius Medical Care stock?
The price to earnings (P/E) ratio for Fresenius Medical Care (FMS) stock is 21.95 as of April 24, 2025.
Does Fresenius Medical Care stock pay dividends?
Yes, the Fresenius Medical Care (FMS) stock pays dividends to shareholders. As of April 24, 2025, the dividend rate is $1.12 and the yield is 2.51%. Fresenius Medical Care has a payout ratio of 55.24% on a trailing twelve-month basis.
When is the next Fresenius Medical Care dividend payment date?
The next Fresenius Medical Care (FMS) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care?
Fresenius Medical Care (FMS) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.